• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有定制效应功能的杂合IgA2/IgG1抗体。

Hybrid IgA2/IgG1 antibodies with tailor-made effector functions.

作者信息

Chintalacharuvu K R, Vuong L U, Loi L A, Larrick J W, Morrison S L

机构信息

Department of Microbiology, Immunology, and Molecular Genetics, Molecular Biology Institute, University of California Los Angeles, 405 Hilgard Avenue, Los Angeles, California 90095, USA.

出版信息

Clin Immunol. 2001 Oct;101(1):21-31. doi: 10.1006/clim.2001.5083.

DOI:10.1006/clim.2001.5083
PMID:11580223
Abstract

Immunoglobulin (Ig) A and IgG are the principal immune effector molecules at mucosal surfaces and in blood, respectively. Mucosal IgA is polymeric and bound to secretory component, whereas serum IgG is monomeric. We have now produced IgA2/IgG1 hybrid antibodies that combine the properties of IgA and IgG. Antibodies with Calpha3 at the end of the IgG H chain resemble IgA and form polymers with J chain that bind the polymeric Ig receptor. Like IgG, the hybrid proteins activated complement and bound FcgammaRI and protein A. Though the hybrid proteins contained both Cgamma2 and Cgamma3, they have a short in vivo half-life. Surprisingly, this decreased half-life correlated with a higher avidity than that of IgG for murine FcRn. Interestingly, antibodies with Calpha1 replacing Cgamma1 were resistant to extremes of pH, suggesting that Calpha1 increases antibody stability. These results provide insights into engineering antibodies with novel combinations of effector functions.

摘要

免疫球蛋白(Ig)A和IgG分别是黏膜表面和血液中的主要免疫效应分子。黏膜IgA是多聚体并与分泌成分结合,而血清IgG是单体。我们现已制备出结合了IgA和IgG特性的IgA2/IgG1杂交抗体。在IgG重链末端带有Cα3的抗体类似于IgA,并与J链形成聚合物,该聚合物可结合多聚免疫球蛋白受体。与IgG一样,杂交蛋白可激活补体并结合FcγRI和蛋白A。尽管杂交蛋白同时包含Cγ2和Cγ3,但它们在体内的半衰期较短。令人惊讶的是,这种缩短的半衰期与对鼠FcRn的亲和力高于IgG相关。有趣的是,用Cα1取代Cγ1的抗体对极端pH具有抗性,这表明Cα1可提高抗体稳定性。这些结果为构建具有新型效应功能组合的抗体提供了思路。

相似文献

1
Hybrid IgA2/IgG1 antibodies with tailor-made effector functions.具有定制效应功能的杂合IgA2/IgG1抗体。
Clin Immunol. 2001 Oct;101(1):21-31. doi: 10.1006/clim.2001.5083.
2
Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.C2相关碳水化合物结构对Ig效应子功能的影响:在中国仓鼠卵巢细胞糖基化突变体中使用嵌合小鼠-人IgG1抗体进行的研究。
J Immunol. 1998 Apr 1;160(7):3393-402.
3
Importance of neonatal FcR in regulating the serum half-life of therapeutic proteins containing the Fc domain of human IgG1: a comparative study of the affinity of monoclonal antibodies and Fc-fusion proteins to human neonatal FcR.新生儿 FcR 在调节含有人 IgG1 Fc 结构域的治疗性蛋白血清半衰期中的重要性:单克隆抗体和 Fc 融合蛋白与人新生儿 FcR 亲和力的比较研究。
J Immunol. 2010 Feb 15;184(4):1968-76. doi: 10.4049/jimmunol.0903296. Epub 2010 Jan 18.
4
Addition of a mu-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4.在IgG上添加一个μ尾段会产生具有增强效应功能的多聚体抗体,包括IgG4介导的补体依赖性细胞溶解。
J Immunol. 1995 Mar 1;154(5):2226-36.
5
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.具有三种不同N-连接Fc寡糖(高甘露糖型、杂合型和复合型)的非岩藻糖基化治疗性IgG1抗体之间的生物学活性比较。
Glycobiology. 2007 Jan;17(1):104-18. doi: 10.1093/glycob/cwl057. Epub 2006 Sep 29.
6
Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life.对小鼠体内具有不同半衰期的一系列抗体进行分析,未能发现与FcRn的亲和力和血清半衰期之间存在相关性。
Mol Immunol. 2006 Mar;43(9):1462-73. doi: 10.1016/j.molimm.2005.07.032. Epub 2005 Sep 1.
7
Identification of IgG(1) variants with increased affinity to FcγRIIIa and unaltered affinity to FcγRI and FcRn: comparison of soluble receptor-based and cell-based binding assays.鉴定对 FcγRIIIa 亲和力增加而对 FcγRI 和 FcRn 亲和力不变的 IgG(1)变体:基于可溶性受体和基于细胞的结合测定法的比较。
J Immunol Methods. 2011 Feb 28;365(1-2):132-41. doi: 10.1016/j.jim.2010.12.014. Epub 2010 Dec 23.
8
Reduced elimination of IgG antibodies by engineering the variable region.通过工程化改造可变区来减少 IgG 抗体的清除。
Protein Eng Des Sel. 2010 May;23(5):385-92. doi: 10.1093/protein/gzq009. Epub 2010 Feb 15.
9
Humanized IgG1 variants with differential binding properties to the neonatal Fc receptor: relationship to pharmacokinetics in mice and primates.对新生儿Fc受体具有不同结合特性的人源化IgG1变体:与小鼠和灵长类动物药代动力学的关系。
Drug Metab Dispos. 2007 Jan;35(1):86-94. doi: 10.1124/dmd.106.011734. Epub 2006 Oct 18.
10
In vitro and in vivo activities of OX40 (CD134)-IgG fusion protein isoforms with different levels of immune-effector functions.具有不同免疫效应功能水平的OX40(CD134)-IgG融合蛋白异构体的体外和体内活性
J Leukoc Biol. 2002 Sep;72(3):522-9.

引用本文的文献

1
The present and future of immunocytokines for cancer treatment.免疫细胞因子在癌症治疗中的现状和未来。
Cell Mol Life Sci. 2022 Sep 6;79(10):509. doi: 10.1007/s00018-022-04514-9.
2
Sagacity in antibody humanization for therapeutics, diagnostics and research purposes: considerations of antibody elements and their roles.用于治疗、诊断和研究目的的抗体人源化中的睿智:抗体元件及其作用的考量
Antib Ther. 2020 Apr 18;3(2):71-79. doi: 10.1093/abt/tbaa005. eCollection 2020 Apr.
3
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents.
推动IgA抗体作为治疗剂的Fc工程策略。
Antibodies (Basel). 2020 Dec 15;9(4):70. doi: 10.3390/antib9040070.
4
Conceptual Approaches to Modulating Antibody Effector Functions and Circulation Half-Life.调节抗体效应功能和循环半衰期的概念方法。
Front Immunol. 2019 Jun 7;10:1296. doi: 10.3389/fimmu.2019.01296. eCollection 2019.
5
Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.单核细胞和巨噬细胞上的FcγR和FcαR同时暴露可增强体内抗肿瘤活性。
Oncotarget. 2017 Jun 13;8(24):39356-39366. doi: 10.18632/oncotarget.17000.
6
The role of Fc receptors in HIV prevention and therapy.Fc受体在HIV预防和治疗中的作用。
Immunol Rev. 2015 Nov;268(1):296-310. doi: 10.1111/imr.12339.
7
Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.通过赋予IgG与FcαRI(CD89)结合能力来增强抗体依赖性细胞介导的细胞毒性。
MAbs. 2015;7(4):743-51. doi: 10.1080/19420862.2015.1047570.
8
Surface silver-doping of biocompatible glass to induce antibacterial properties. Part I: Massive glass.生物相容性玻璃的表面银掺杂以诱导抗菌性能。第一部分:块状玻璃。
J Mater Sci Mater Med. 2009 Mar;20(3):733-40. doi: 10.1007/s10856-008-3617-9. Epub 2008 Nov 6.
9
Early stage reactivity and in vitro behavior of silica-based bioactive glasses and glass-ceramics.硅基生物活性玻璃和玻璃陶瓷的早期反应性及体外行为
J Mater Sci Mater Med. 2009 Jan;20(1):75-87. doi: 10.1007/s10856-008-3537-8. Epub 2008 Aug 14.